Abstract
Cancer, as one of the leading causes of global mortality, demands highly effective therapeutic approaches and the identification of highly specific biomarkers for accurate diagnosis and prognosis. In this context, sphingolipids emerge as key players due to their implications in the cancer landscape. Ceramide, a well-known sphingolipid with anti-tumoral properties, takes a prominent role. …